Phase II study of gemcitabine combined with oxaliplatin in relapsed or refractory paediatric solid malignancies: An innovative therapy for children with Cancer European Consortium Study

2011 ◽  
Vol 47 (2) ◽  
pp. 230-238 ◽  
Author(s):  
Birgit Geoerger ◽  
Julia Chisholm ◽  
Marie-Cecile Le Deley ◽  
Jean-Claude Gentet ◽  
Christian Michel Zwaan ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Study ◽  
Children With Cancer ◽  
Innovative Therapy ◽  
Solid Malignancies

scholarly journals A phase II study of everolimus in patients with advanced solid malignancies with TSC1, TSC2, NF1, NF2 or STK11 mutations

2021 ◽  
Vol 0 (0) ◽  
pp. 0-0
Author(s):  
Siddhartha Devarakonda ◽  
Bruna Pellini ◽  
Luke Verghese ◽  
Haeseong Park ◽  
Daniel Morgensztern ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Study ◽  
Solid Malignancies

Phase II study of temozolomide in combination with topotecan (TOTEM) in relapsed or refractory neuroblastoma: A European Innovative Therapies for Children with Cancer-SIOP-European Neuroblastoma study

2014 ◽  
Vol 50 (1) ◽  
pp. 170-177 ◽  
Author(s):  
Angela Di Giannatale ◽  
Nathalie Dias-Gastellier ◽  
Annick Devos ◽  
Kieran Mc Hugh ◽  
Ariane Boubaker ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Study ◽  
Children With Cancer ◽  
Innovative Therapies

Phase II study of safety, efficacy and pharmacokinetics of BXT-51072 in patients with mild-moderately active ulcerative colitis

2001 ◽  
Vol 120 (5) ◽  
pp. A280-A280
Author(s):  
S HANAUER ◽  
P MINER ◽  
A KESHAVARZIAN ◽  
E MORRIS ◽  
B SALZBERG ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Active Ulcerative Colitis
Sign in / Sign up

Export Citation Format

Share Document